###begin article-title 0
###xml 148 149 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 894 895 882 883 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Bcl-2 family proteins are key regulators of mitochondrial integrity and comprise both pro- and anti-apoptotic proteins. Bax a pro-apoptotic member localizes as monomers in the cytosol of healthy cells and accumulates as oligomers in mitochondria of apoptotic cells. The Bcl-2 homology-3 (BH3) domain regulates interactions within the family, but regions other than BH3 are also critical for Bax function. Thus, the N-terminus has been variously implicated in targeting to mitochondria, interactions with BH3-only proteins as well as conformational changes linked to Bax activation. The transmembrane (TM) domains (alpha5-alpha6 helices in the core and alpha9 helix in the C-terminus) in Bax are implicated in localization to mitochondria and triggering cytotoxicity. Here we have investigated N-terminus modulation of TM function in the context of regulation by the anti-apoptotic protein Bcl-xL.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 276 278 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 484 486 476 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 604 606 596 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 697 698 689 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 758 759 750 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 922 924 914 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1006 1007 990 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 1172 1174 1156 1158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Deletion of 29 amino acids in the Bax N-terminus (Bax 30-192) caused constitutive accumulation at mitochondria and triggered high levels of cytotoxicity, not inhibited by Bcl-xL. Removal of the TM domains (Bax 30-105) abrogated mitochondrial localization but resulted in Bcl-xL regulated activation of endogenous Bax and Bax-Bak dependent apoptosis. Inclusion of the alpha5-alpha6 helices/TMI domain (Bax 30-146) phenocopied Bax 30-192 as it restored mitochondrial localization, Bcl-xL independent cytotoxicity and was not dependent on endogenous Bax-Bak. Inhibition of function and localization by Bcl-xL was restored in Bax 1-146, which included the TM1 domain. Regardless of regulation by Bcl-xL, all N-terminal deleted constructs immunoprecipitated Bcl-xLand converged on caspase-9 dependent apoptosis consistent with mitochondrial involvement in the apoptotic cascade. Sub-optimal sequence alignments of Bax and Bcl-xL indicated a sequence similarity between the alpha5-alpha6 helices of Bax and Bcl-xL. Alanine substitutions of three residues (T14A-S15A-S16A) in the N-terminus (Bax-Ala3) attenuated regulation by the serine-threonine kinase Akt/PKB but not by Bcl-xL indicative of distinct regulatory mechanisms.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 162 163 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 250 252 250 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Collectively, the analysis of Bax deletion constructs indicates that the N-terminus drives conformational changes facilitating inhibition of cytotoxicity by Bcl-xL. We speculate that the TM1 helices may serve as 'structural antagonists' for BH3-Bcl-xL interactions, with this function being regulated by the N-terminus in the intact protein.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 571 572 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 709 710 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 711 712 711 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Bcl-2 family proteins are central to the regulation of mitochondrial integrity and cell death pathways that converge on this organelle [1,2]. This family comprises both pro-survival (Bcl-2, Bcl-xL, Mcl-1, Bcl-w) and pro-apoptotic (Bax, Bak, Bim, Bid, Bad) proteins. All members of this family are characterized by the presence of BH (Bcl-2 homology) domain(s) [3,4]. Bax is a multidomain pro-apoptotic member of the Bcl-2 family, characterized by the presence of BH 1-3 domains. The BH3 domain regulates Bax homodimerization as well as heterodimerization with Bcl-2/Bcl-xL[5,6], such that the Bax-BH3 domain docks into the hydrophobic groove formed by BH1, BH2 and BH3 domains of the anti-apoptotic proteins [7-9]. Selectivity in interactions between pro- and anti-apoptotic members of the Bcl-2 family has been reported [10].
###end p 9
###begin p 10
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 543 545 543 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 816 818 816 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1005 1007 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1008 1010 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Changes in Bax conformation and localization are characteristic of many cells undergoing apoptosis [11-13]. In dying cells a conformationally distinct form of (activated) Bax accumulates at the mitochondrial outer membrane triggering the release of apoptogenic intermediates sequestered in the mitochondrial intermembrane space [14]. Several studies have yielded insights on the molecular mechanisms regulating Bax activation [15-18] and the N-terminus is implicated in this function. Controlled cleavage of the Bax N-terminus by calpain, a Ca2+-dependent cysteine protease generates a dominantly active form of Bax [19-21]. Short forms of Bax deleted of the first 28 or 32 amino acids are highly cytotoxic, largely associated with mitochondrial membrane and poorly inhibited by ectopically expressed Bcl-2 and Bcl-xL [22,23]. Two splice variants Bax psi and Bax kappa lack 19 amino acids present at the N-terminal of Bax-alpha and are potent inducers of cytotoxicity when ectopically expressed in cells [24,25].
###end p 10
###begin p 11
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 428 430 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 629 631 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 776 778 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 779 781 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 908 909 888 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 1066 1067 1046 1047 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Specific regions in the N and C terminus are implicated in the regulated mitochondrial targeting of Bax [26-28]. However, recombinant Bax protein lacking these regions retains mitochondrial targeting and insertion capabilities [27,29,30] because of two putative transmembrane (TM) regions, one encompassing the alpha5-alpha6 helices (amino acids 110-146) and the second the alpha9 helix (amino acids 172-188) at the C-terminus [31]. These are referred to as TM1 and TM2 respectively in this study. Recent experiments have shown that both TM1 and TM2 span the lipid bilayer in the membrane fraction of cells undergoing apoptosis [32]. Additionally other reports have identified a role for the alpha5-alpha6 helices in mitochondrial membrane insertion and cytochrome c release [29,33]. In the present study the TM1 domain and N-terminus have been characterized in the context of regulation of activity by Bcl-xL. Specifically, the experiments suggest that interactions between the N-terminus and TM1 region in intact Bax, modulate susceptibility to inhibition by Bcl-xL.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 136 137 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Apoptosis triggered by a Bax N-terminal deletion mutant (Bax 30-192) is poorly inhibited by the anti apoptotic proteins, Bcl-2 and Bcl-xL
###end title 13
###begin p 14
###xml 119 121 119 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 201 203 201 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 329 352 329 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 494 504 494 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 329 352 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Apoptosis triggered by a deletion mutant that lacks the first 29 amino acids (Bax 30-192) was poorly inhibited by Bcl-xL (Figure 1A) or Bcl-2 (Figure 1B) in the Jurkat T-cell line. Since Bcl-2 or Bcl-xL function may be modulated by other pro-apoptotic proteins present in mammalian cells, we turned to the heterologous system of Drosophila melanogaster, which expresses only one pro- and one anti-apoptotic protein of the Bcl-2 family [34]. We hypothesized that by expressing these proteins in Drosophila, modulation by an endogenous modifier (if indeed it occurs) will be independent of the construct being tested and will be equivalent in all conditions.
###end p 14
###begin p 15
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of Bax and Bax 30&#8211;192 by Bcl-2 and Bcl-x<sub>L</sub></bold>
###xml 133 135 130 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Inhibition of Bax and Bax 30-192 by Bcl-2 and Bcl-xL. A, GFP (1 mug), Bax-GFP (3 mug) or Bax 30-192-GFP (3 mug) with or without Bcl-xL (5 mug) were transfected in Jurkat cells. GFP positive cells were assessed for apoptotic nuclear damage. B, Jurkat cells were transfected with GFP (1 mug), Bax-GFP (3 mug) or Bax 30-192-GFP (3 mug) with or without Bcl-2 (5 mug) and assessed for apoptotic nuclear damage 12 hours post-transfection. The data are presented as mean +/- SD derived from three-four independent experiments. *p < 0.001
###end p 15
###begin p 16
###xml 160 171 160 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 436 445 436 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-GAL4 </italic>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Bax-GFP, Bax 30-192-GFP and Bcl-2 were cloned into the pUAST vector and expression of the tagged proteins at the appropriate molecular weights confirmed in the Drosophila S2 cell line (Figure 2A). Transgenic fly lines of Bax, Bax 30-192 and Bcl-2 were generated by independent P-element transformation of the UAS-Bax-GFP (BA64III and BA13I), UAS-Bax30-192-GFP (DBA8II and DBA8IA) and UAS-Bcl-2 (BC57I and BC24III) constructs. Using the UAS-GAL4 system both Bax and Bax 30-192 were lethal to flies when driven in various tissues while Bcl-2 expression alone was not lethal (Table 1). This allowed us to test for the rescue of lethality by Bcl-2.
###end p 16
###begin p 17
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL4 </italic>
Percent viability with tissue specific GAL4 drivers
###end p 17
###begin p 18
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS </italic>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL4 </italic>
UAS transgenic lines for Bax-GFP (BA64III) or Bax 30-192-GFP (DBA8II) or Bcl-2 (BC57I) were screened for lethality using various tissue specific GAL4 lines as indicated. Percent viability was calculated by assessing the number of Bax-GFP or Bax 30-192-GFP or Bcl-2 expressing flies compared to the appropriate sibling control that eclosed at 25degreesC. Numbers in parenthesis indicate animals screened for analysis.
###end p 18
###begin p 19
###xml 60 83 60 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The N-terminal deletion mutant is not regulated by Bcl-2 in <italic>Drosophila melanogaster</italic></bold>
###xml 60 83 <span type="species:ncbi:7227">Drosophila melanogaster</span>
The N-terminal deletion mutant is not regulated by Bcl-2 in Drosophila melanogaster. A, Cell lysates of S2 cells transfected with UAS-GFP (lane 1), UAS-Bax-GFP (lane 2) or UAS-Bax 30-192-GFP (lane 3) along with actin-GAL4 for 24 hours were assessed by western blot analysis using an anti -GFP antibody. B, Viability of flies was assessed in the indicated UAS transgenic lines driven at 25degreesC by vg-GAL4 (left panel) or twist-GAL4 (right panel). Viability is represented as the percentage of eclosed adult flies expressing Bax-GFP or Bax 30-192-GFP with respect to the appropriate sibling controls. The numbers over each bar indicate the total number of flies screened in the group. C-H, Wing phenotypes in vg-GAL4 flies sibling controls (C); transgenic fly lines of UAS-Bax-GFP (D); UAS-Bax 30-192-GFP (E); Bcl-2 (F); Bax-GFP + Bcl-2 (G) or Bax 30-192-GFP + Bcl-2 (H). I, Wing phenotypes of flies expressing Bax-GFP or Bax 30-192-GFP were categorized as illustrated. Representative images are shown. Arrow indicates notched margin of the wing obtained in few animals.
###end p 19
###begin p 20
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vg-GAL4 </italic>
###xml 35 46 35 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist-GAL4 </italic>
###xml 198 206 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vg-GAL4 </italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 216 226 216 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 231 242 231 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist-GAL4 </italic>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 254 265 254 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vg-GAL4</italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 909 917 909 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-Bax </italic>
###xml 926 940 926 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-Bax 30&#8211;192</italic>
###xml 953 963 953 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-Bcl-2 </italic>
###xml 1021 1029 1021 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vg-GAL4 </italic>
###xml 1057 1058 1057 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1122 1146 1122 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster </italic>
###xml 1122 1145 <span type="species:ncbi:7227">Drosophila melanogaster</span>
For these experiments, vg-GAL4 and twist-GAL4 lines were used to drive expression largely in the dorsal margins of wings and mesoderm respectively. When driven along with Bax (BA64III, BC57I) using vg-GAL4 (Figure 2Bleft panel) or twist-GAL4 (Figure 2B, right panel) Bcl-2 rescued Bax induced lethality whereas Bax 30-192 (DBA8II, BC57I) induced lethality was only marginally rescued. Flies expressing Bax or Bax 30-192 (using vg-GAL4) present deformity in wings to various degrees (Figure 2I). All the flies that emerged for Bax (BA64III) and Bax 30-192 (DBA8II) presented a strong wing defect (Figure 2D and 2E). Bcl-2 co expression with Bax in the double transgenic fly line BA64III, BC57I resulted in complete rescue of the wing defect (Figure 2G) while there was no change in the severe wing defect in Bax 30-192 and Bcl-2 (DBA8II, BC57I) expressing flies (Figure 2H). Additional transgenic fly lines of UAS-Bax (BA13I), UAS-Bax 30-192(DBA8IA) and UAS-Bcl-2 (BC24III) were tested for viability and wing defect using vg-GAL4 with similar results (Table 2). Thus, the experiments using the heterologous model system of Drosophila melanogaster recapitulated the observation of inefficient inhibition of Bax 30-192 by anti-apoptotic proteins in mammalian cells.
###end p 20
###begin p 21
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vg-GAL</italic>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS </italic>
Percent viability and extent of wing defect with vg-GAL4 for additional UAS transgenic lines
###end p 21
###begin p 22
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS </italic>
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 </italic>
###xml 165 167 165 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vg</italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL4 </italic>
Additional UAS transgenic lines for Bax-GFP (BA13I) or Bax 30-192-GFP (DBA8IA) or Bax-GFP+Bcl-2 (BA13I; BC24III) or Bax 30-192-GFP+Bcl-2 (DBA8IA; BC24III) driven by vg-GAL4 were assessed for the viability of flies at 25degreesC as described in Figure 2B. The eclosed adult flies expressing Bax-GFP or Bax 30-192-GFP were analyzed for the extent of wing defect and categorized as depicted in Figure 2I. The percentage of flies for the wing defect was calculated with respect to the total number of eclosed flies expressing Bax-GFP or Bax 30-192-GFP. Numbers in parenthesis indicate flies screened for analysis.
###end p 22
###begin title 23
###xml 84 85 84 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Apoptosis triggered by transmembrane -1 (TM1) deletion mutants is inhibited by Bcl-xL
###end title 23
###begin p 24
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 637 639 637 639 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
To assess the contributions of the TM domains in Bax 30-192 cytotoxicity, additional regions were deleted (Figure 3A). Apoptosis triggered by a mutant devoid of the C-terminal TM2 domain (Bax 30-171) is Bcl-2 independent, whereas apoptosis triggered by Bax 1-171 is inhibited (Figure 3B). However, it should be noted that apoptosis triggered by this construct was considerably lower than that triggered by full-length Bax thereby confounding interpretation of the data. Bax 30-105 which lacks any putative or experimentally proven TM domain but retains the BH3 domain triggered high levels of apoptotic damage, which was blocked by Bcl-xL or Bcl-2 (Figure 3C).
###end p 24
###begin p 25
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Apoptosis triggered by TM deletion mutants is inhibited by Bcl-x<sub>L</sub></bold>
###xml 674 676 672 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 802 804 796 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 860 862 853 855 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Apoptosis triggered by TM deletion mutants is inhibited by Bcl-xL. A, Schematic representation of the GFP tagged Bax constructs used in functional assays. The numerals indicate the amino acid residue number in the Bax protein (192 amino acids). TM1: transmembrane domain 1, TM2: transmembrane domain 2. B-D, Apoptotic nuclear damage in cells assessed 12-15 hours post-transfection in B, Jurkat cells transfected with GFP, Bax 30-171-GFP or Bax 1-171-GFP with or without Bcl-2 as indicated. The data in the figure is normalized to nuclear damage in GFP or GFP + Bcl-2 transfected cells. C, Jurkat cells transfected with GFP, Bax 30-105-GFP (3 mug) with Bcl-2 (3 mug) or Bcl-xL (3 mug). D, HEK cells transfected with Bax-GFP (1 mug), Bax 30-192-GFP (1 mug) or Bax 30-105-GFP (1 mug) with or without Bcl-xL (1 mug). Inset, shows the levels of Bax, Bcl-2 and Bcl-xL as determined by western blot analysis of the Jurkat and HEK cell lines. The data are presented as mean +/- SD derived from a minimum of three independent experiments. **p < 0.01; *p < 0.001.
###end p 25
###begin p 26
###xml 59 61 59 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 423 425 423 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
We then tested the deletion mutants for regulation by Bcl-xL in the HEK cell line as the larger size and adherent nature of the cells facilitates assessment of apoptotic damage and subcellular distribution of GFP-tagged proteins. Bax induced apoptosis was effectively blocked by Bcl-xL; apoptosis triggered by Bax 30-192 was poorly inhibited, and apoptosis triggered by Bax 30-105 was blocked by ectopically expressed Bcl-xL in this cell line (Figure 3D). Jurkat cells express lower levels of Bax protein compared to the HEK cell line arguing against interactions with endogenous Bax accounting for the responses of the deletion mutants.
###end p 26
###begin title 27
###xml 5 7 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Bcl-xL regulation of Bax 30-192 and Bax 30-105 colocalization with Bid and Bim
###end title 27
###begin p 28
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 259 260 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 643 645 643 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
The first alpha helix (amino acids 16-35) in the Bax N-terminus is implicated in interactions with activator BH3-only proteins [15,28,29]. In apoptotic cells, Bax clusters co-localized with Bid or Bim (Figure 4A and 4B, upper panel). In cells expressing Bcl-xL, Bid and Bim are evenly distributed and do not overlap Bax-GFP (Figure 4A and 4B, lower panel). Bax 30-192-GFP tends to coalesce into a large cluster and overlaps with regions of intense staining with Bid or Bim (Figure 4C and 4D upper panel). However, there is no change in the largely punctate distribution of Bax 30-192 or the overlap with Bid or Bim in cells co-expressing Bcl-xL (Figure 4C and 4D, lower panel).
###end p 28
###begin p 29
###xml 5 7 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Bcl-x<sub>L </sub>regulation of colocalization with Bid and Bim in HEK cells</bold>
###xml 123 125 123 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 312 314 312 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Bcl-xL regulation of colocalization with Bid and Bim in HEK cells. A and B, HEK cells transfected with Bax or Bax and Bcl-xL were stained for Bid or Bim. C and D, As in A, except that cells were transfected with Bax 30-192 with or without Bcl-xL. E and F, Cells transfected with Bax 30-105 with and without Bcl-xL were stained with clone 6A7 and Bid or Bim. Nuclear morphology was assessed by staining with Hoechst 33342. Single confocal planes of cells imaged at 60x magnification are shown. Scale bar: 10 microns.
###end p 29
###begin p 30
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 559 561 559 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 701 703 701 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
Since Bax 30-105 triggered Bcl-xL dependent apoptosis although it did not localize to mitochondria (Figure 5D), we asked if it triggered the activation of endogenous Bax. Changes in Bax conformation consistent with its activation reveal an epitope in the N-terminus that can be detected using a specific antibody clone 6A7 [35]. Bax 30-105 lacks the relevant section of the N-terminus, and 6A7 reactivity in cells expressing Bax 30-105 indicated the activation of endogenous Bax (Figure 4E). This reactivity was lost in cells that express Bax 30-105 and Bcl-xL (Figure 4F). Further, endogenous Bax as detected by the reactivity of clone 6A7 colocalized with Bid and Bim and this was regulated by Bcl-xL (Figure 4E and 4F).
###end p 30
###begin p 31
###xml 44 45 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The TM1 domain regulates inhibition by Bcl-x<sub>L</sub></bold>
###xml 172 174 171 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 857 861 <span type="species:ncbi:262676">Mito</span>
The TM1 domain regulates inhibition by Bcl-xL. A, Schematic representation of Bax and Bax 30-146. B, HEK cells transfected with Bax 30-146-GFP (1 mug) with or without Bcl-xL (1 mug) and assessed for apoptotic nuclear damage after 15 hours of culture. Data are normalized for apoptotic damage triggered by GFP alone in both conditions. C, HEK cells were transfected with 1 mug GFP or Bax-GFP or Bax 30-146-GFP or Bax 30-105-GFP with or without 2 mug dominant negative caspase 9 (DNC9). Apoptotic nuclear damage was assessed after 15 hours of culture. Data is normalized to damage in cells transfected with GFP alone or GFP + DNC9 transfected cells. D, HEK cells transfected with Bax-GFP or Bax 30-146-GFP or Bax 30-105-GFP were harvested after 15 hours of culture and subjected to sub-cellular fractionation. The cytosolic (Cyto) and membrane/mitochondrial (Mito) fractions were assessed for GFP and Cox4 distribution by western blot analysis. WCL: whole cell lysate. Values in the anti-GFP blots are derived from densitometry analysis and indicate the amount of GFP detected in the specific fraction relative to the total signal in the mitochondria and cytosol fractions. The data are presented as mean +/- SD derived from a minimum of three independent experiments. **p < 0.01; *p < 0.001.
###end p 31
###begin title 32
###xml 79 81 79 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
In the absence of the N-terminus, the TM1 domain attenuates inhibition by Bcl-xL but triggers caspase-9 dependent apoptosis
###end title 32
###begin p 33
###xml 138 140 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 157 159 149 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 192 194 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 279 280 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 343 345 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 511 513 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 514 516 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 668 670 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
A construct that included the TM1 domain comprising the alpha5-alpha6 helices, but not the N-terminal 29 amino acids (Bax 30-146) (Figure 5A) triggered Bcl-xL independent cytotoxicity (Figure 5B) indicating that the TM1 domain interfered with the anti-apoptotic function of Bcl-xL. Since Bax function converges on the activation of caspase-9 [36] we analyzed apoptotic damage induced by Bax, Bax 30-146 or Bax 30-105 when co-expressed with a construct that is a dominant-negative inhibitor of caspase-9 (DNC9) [37,38]. Apoptosis triggered by all the mutants tested, including Bax 30-192 (data not shown) was blocked by the co-transfection of DNC9 in HEK cells (Figure 5C) and in the Jurkat cell line (data not shown). The data show that all the constructs tested activate a caspase-9 mediated apoptotic cascade as has been established for Bax.
###end p 33
###begin p 34
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper </italic>
###xml 277 289 277 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle panel</italic>
Sub-cellular fractionation of HEK cells (Figure 5D) transfected with the relevant constructs showed that Bax is present in both the cytosolic and mitochondrial fractions, whereas increased amounts of Bax 30-146 was detected in the mitochondrial fractions (Figure 5D, upper and middle panel). In many experiments, the distribution of Bax 30-146 and Bax 30-192 was skewed to the mitochondrial fraction (not shown). Expectedly, Bax 30-105 was consistently detected only in the cytosolic fraction. The mitochondrial matrix protein Cox-4 was used to ascertain purity of the fractions.
###end p 34
###begin title 35
###xml 5 7 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Bcl-xL associates with but does not regulate the localization of N-terminal deletion constructs
###end title 35
###begin p 36
###xml 97 99 97 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 164 165 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 327 329 327 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 339 340 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 493 495 493 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 563 565 563 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 669 671 669 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 888 890 888 890 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
Subsequently we assessed the cellular distribution of the constructs using GFP to report on Bcl-xL regulation of Bax localization. In the absence of exogenous Bcl-xL, the distribution of Bax, Bax 30-146 and Bax 30-192 is punctate in apoptotic cells whereas, Bax 30-105 is diffuse (Figure 6A). In cells co-transfected with Bcl-xL (RFP-Bcl-xL), Bax distribution is rendered diffuse (Figure 6B) as opposed to Bax 30-146 or Bax 30-192, where the punctate distribution is largely unchanged by Bcl-xL (Figure 6B). The distribution of Bax 30-105 was not changed by Bcl-xL (Figure 6B). The distribution of Bax in punctate or diffuse patterns in the presence or absence of Bcl-xL is plotted in Figure 6C. The values are derived from an assessment of approximately 200 cells in random fields in each experiment. This experiment shows that in Bax constructs which lack the first 29 amino acids Bcl-xL regulation of cellular distribution is compromised.
###end p 36
###begin p 37
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The Bax N-terminus or TM1 domain is not essential for association with Bcl-x<sub>L</sub></bold>
###xml 176 178 176 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 408 410 408 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 919 921 919 921 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 959 961 959 961 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1001 1003 1001 1003 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1064 1066 1064 1066 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
The Bax N-terminus or TM1 domain is not essential for association with Bcl-xL. A, HEK cells transfected with Bax-GFP, Bax 30-192GFP, Bax 30-146 GFP, Bax 30-105 GFP or RFP-Bcl-xL were harvested after 15 hours and imaged using confocal microscopy. Representative images (processed as described in methods) are shown. Scale bar: 10 microns B, HEK cells transfected with each of the constructs in A and RFP-Bcl-xL were harvested 15 hours post-transfection. Confocal images for distribution of Bax constructs (green) and RFP-Bcl-xL (red) were assessed for co-localization (Merge, right panel). Scale Bar: 10 microns. Representative images (each corresponding to a single image field) are shown. C, From the experiment in B, cells positive for GFP and RFP were scored for punctate or diffuse patterns of GFP by microscopy. The data are representative of two independent analyses. D, HEK cells transfected with Bax-GFP + Bcl-xL (left panel) or Bax 30-146-GFP + Bcl-xL (middle panel) or Bax 30-105-GFP + Bcl-xL (right panel) were harvested after 15 hours of culture. Bcl-xL was immunoprecipitated from cell lysates and the immunoprecipitates assessed by western blot analysis for Bax or the mutant constructs using an antibody to GFP and for the presence of actin. WCL represents the CHAPS buffer solubilized whole cell lysate, which was used for immunoprecipitation.
###end p 37
###begin p 38
###xml 27 29 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 142 143 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Ectopically expressed Bcl-xL immunoprecipitated cotransfected Bax, Bax 30-146 or Bax 30-105 (Figure 6D) indicating that association with Bcl-xLis not impaired in the absence of the first twenty nine residues in Bax protein.
###end p 38
###begin title 39
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
The Bax N-terminus regulates inhibition by Bcl-xL
###end title 39
###begin p 40
###xml 11 13 11 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 267 269 267 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 316 318 316 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 529 531 529 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 615 617 615 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 703 705 703 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
Since Bcl-xL poorly regulated Bax 30-146 or 30-192 despite the association with the protein, we tested if the N-terminus can modulate this function. Apoptosis triggered by Bax 1-146 which includes the N-terminus and the TM1 domain was efficiently blocked by RFP-Bcl-xL (Figure 7A). Bax 1-146 immunoprecipitates Bcl-xL and is detected in both mitochondrial and cytosolic fractions (Figure 7B). Furthermore, the punctate distribution of Bax 1-146 in apoptotic cells redistributes to a diffuse pattern in cells that co-express Bcl-xL (Figure 7C). The distribution of Bax 1-146 overlaps significantly with that of Bcl-xL (Figure 7C). The change in distribution of Bax 1-146 in response to co-expressed Bcl-xL is shown (Figure 7D). In a construct that lacks the TM domains, the N-terminus did not modulate Bax-BH3 function (Figure 7E).
###end p 40
###begin p 41
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The Bax N-terminus regulates susceptibility to inhibition by anti-apoptotic molecules</bold>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 282 284 282 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 334 336 334 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1071 1073 1071 1073 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1372 1374 1372 1374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1585 1587 1583 1585 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1753 1755 1751 1753 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 718 722 <span type="species:ncbi:262676">Mito</span>
###xml 1561 1565 <span type="species:ncbi:262676">Mito</span>
###xml 1723 1727 <span type="species:ncbi:262676">Mito</span>
The Bax N-terminus regulates susceptibility to inhibition by anti-apoptotic molecules. A, Apoptotic nuclear damage (15 hours post-transfection) was assessed in HEK cells transfected with Bax 1-146-GFP with or without RFP-Bcl-xL. B, HEK cells transfected with Bax 1-146 GFP and Bcl-xL were harvested after 15 hours of culture and Bcl-xL immunoprecipitated from the cell lysate. The precipitated complex was analyzed for Bax 1-146-GFP and actin by western blot analysis. WCL is the CHAPS buffer-solubilized whole cell lysate used in the immunoprecipitation. HEK cells transfected with Bax 1-146-GFP were harvested 15 hours post-transfection and processed to enrich for the cytosol (Cyto) and the membrane/mitochondrial (Mito) fractions. The distribution of GFP and Cox4 was determined by western blot analysis. WCL represents the whole cell lysate. Numbers below the blots are the densitometric analysis of the GFP signal in the specific fraction relative to the total in the mitochondria and cytosol fractions. C, HEK cells expressing Bax 1-146 alone or Bax 1-146+RFP-BclxL were assessed for distribution as described in 6B. E, Apoptotic nuclear damage was assessed in HEK cells 18-20 hours following transfection with combinations of constructs shown in the panels. F and G, Regulation of Bax and Bax-Ala3 induced apoptosis by constitutively active (CA)- Akt (F) and Bcl-xL (G). The data in all panels are presented as mean +/- SD and are derived from three-five independent experiments. H and I, HEK cells transfected with Bax-GFP or Bax-Ala-3 with CA-Akt and Mito-dsRed2 or RFP-Bcl-xL where indicated were harvested 15 hours post-transfection. Confocal images for distribution of GFP tagged constructs of Bax (green) and Mito-dsRed2 (red) or RFP-Bcl-xL (red) were assessed for co-localization (Merge). Scale Bar: 10 microns. Representative images (each corresponding to a single image field) are shown. *p < 0.001
###end p 41
###begin p 42
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7H</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7H</xref>
###xml 502 504 502 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7G</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7I</xref>
Phosphorylation dependent modifications that change protein conformation regulate the apoptotic function of Bcl-2 family proteins. Bax-induced apoptosis is inhibited by the serine-threonine kinase Akt (Figure 7F and 7H). This regulation was compromised in a Bax construct (Bax-Ala3) with alanine substitutions of the Ser/Thr residues (T14, S15, S16) in the N-terminus which was refractory to inhibition by Akt (Figure 7F and 7H). The modification in the N-terminus however, did not interfere with Bcl-xL inhibition of Bax-Ala3 induced apoptosis (Figure 7G and 7I).
###end p 42
###begin title 43
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
The N-terminus regulates sensitivity to inductive stimuli and inhibition by Bcl-xL
###end title 43
###begin p 44
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 321 323 321 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 544 546 544 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 656 658 656 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 780 782 780 782 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E</xref>
The deletion mutants were tested in a cellular system where Bax activity is regulated by externally applied stimuli [11,39]. In Cos-7 cells, staurosporine (STS) triggered the translocation of ectopically expressed Bax and was a potent inducer of Bax-mediated cytotoxicity, which was inhibited in cells co-expressing Bcl-xL (Figure 8A). Bax 30-192 and Bax 30-146 localized into puncta (data not shown) or large clusters and triggered high levels of apoptotic damage which were not further enhanced by STS (Figure 8B and 8C) or inhibited by Bcl-xL (Figure 8B and 8C). Bax 1-146 is largely diffuse but also localizes as puncta and is a potent inducer of Bcl-xL dependent cytotoxicity in response to STS (Figure 8D). Bax 30-105 triggered apoptosis in the absence of STS although Bcl-xL inhibited apoptotic damage in the presence or absence of the apoptotic stimulus (Figure 8E).
###end p 44
###begin p 45
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Responses of Bax deletion mutants to an inductive stimulus</bold>
Responses of Bax deletion mutants to an inductive stimulus. A-E, Cos-7 cells were transfected with indicated constructs as described in methods and apoptotic nuclear damage assessed 3-4 hours after the addition of STS (gray bars). The bars in black indicate apoptotic damage in the absence of STS. F, MEF that are deficient for both Bax and Bak were assessed for susceptibility to Bax, Bax 30-105 and Bax 30-192. Bax 30-105 was tested in the presence (gray bars) or absence (black bars) of STS. *p < 0.001
###end p 45
###begin p 46
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8F</xref>
The data thus far suggested that apoptosis triggered by Bax 30-146 and Bax 30-192 should not depend on endogenous Bax or Bak, whereas Bax 30-105 induced apoptosis may depend on these proteins. MEF deficient for both Bax and Bak were therefore tested for susceptibility to apoptosis by the Bax deletion mutant constructs. Confirming these predictions Bax and Bax 30-192 but not Bax 30-105 triggered apoptosis in Bax/Bak deficient cells (Figure 8F).
###end p 46
###begin title 47
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
TM1 helices of full-length Bax are structural antagonists to Bcl-xL
###end title 47
###begin p 48
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 842 844 842 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 893 895 893 895 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1212 1214 1204 1206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1272 1274 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 1337 1339 1329 1331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1427 1429 1411 1413 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1475 1476 1459 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1589 1591 1573 1575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1637 1639 1621 1623 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1717 1719 1701 1703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 340 345 <span type="species:ncbi:9606">human</span>
In an attempt to elucidate structural correlates if any, of the phenotypes presented by the mutants we turned to a sequence-based analysis of the interacting proteins. The three-dimensional structures of full-length Bax sequence and deletion mutants have been obtained from homology modeling, using MODELLER (version 8v1) starting from the human protein that has 92% sequence identity. The homology model of Bax was examined using the program DIAL [40]. The deletion experiments, using mutants lacking the first 29 residues, suggest that major structural alterations in full-length Bax involving the N-terminal 29 residues, influence the penultimate helix connecting TM1 and TM2 regions in the three-dimensional model of full-length Bax (Figure 9A). In order to test if there is structural equivalence between the anti-apoptotic protein Bcl-xL and regions in Bax, we examined full-length Bcl-xL and Bax for sub-optimal sequence similarity. A high gap penalty of 400 was employed to align the two sets of sequences using MALIGN [41]. In particular, we notice that the first helix of TM1 (TM1.1 helix) and the second helix of TM1 (TM1.2 helix) have significant sequence similarity with alpha-5 and alpha-6 of Bcl-xL and related anti-apoptotic proteins, respectively (Figure 9B). This is supported by previous structural studies where Bcl-xL was co-crystallized with BH3-region of Bim and both helices alpha-5 and alpha-6 of Bcl-xL in this complex interact with the BH3 of Bim [9]. This suggests that the presence of TM1 region could act as structural antagonists for the interaction of Bcl-xL with Bax. Furthermore, the BH2 region of Bcl-xL shows local sequence similarity with the penultimate BH2 helix in Bax (Figure 9C).
###end p 48
###begin p 49
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Structural and sequence analyses of Bax and Bcl-x</bold>
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 50 58 50 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">proteins</bold>
###xml 841 842 841 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Structural and sequence analyses of Bax and Bcl-xLproteins. A, Schematic representation of the spatial interactions between different segments of full-length Bax. The homology model of Bax was examined using the program DIAL [40], originally meant for recognizing compact structural domains in proteins. Structural segments with similar shading form spatial clusters and subdomains. The BH2 region (residues 145-170) forms a cluster with the N-terminal 29-residues indicating spatial proximity between the two segments. B, Sub-optimal sequence alignment between the helices in TM1 region of representative pro-apoptotic family members and alpha-5 of anti-apoptotic proteins. Protein names and residue numbers are marked for the sake of clarity. C, As for B, but showing the alignment between the BH2 helix of pro-apoptotic proteins and Bcl-xL.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 128 130 128 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 428 430 428 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 566 568 566 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 713 714 713 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
The BH3 domain is critical to several interactions within the Bcl-2 family [5-9] and the anti-apoptotic proteins Bcl-2 and Bcl-xL regulate Bax via interactions involving this domain [5,42]. However, mutations in the Bax-BH3 domain which disrupt interactions with pro-survival proteins do not always disrupt regulation by the latter [17,43-45]. The N-terminus of Bax is implicated in the regulation of its function by Bcl-2/Bcl-xL and activator BH3-only proteins [[15,22,23] and [46]]. Here we show that the BH3 and TM1 domains are adequate for association with Bcl-xL and localization to mitochondria respectively, but an intact N-terminus plays a non-redundant role in the regulation of Bax cytotoxicity by Bcl-xL.
###end p 51
###begin p 52
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 23 25 23 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 108 110 108 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B&#8211;C</xref>
###xml 286 288 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 289 291 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 489 491 473 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 492 494 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 559 560 543 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 640 642 624 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 650 652 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 803 805 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 806 808 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 809 811 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 812 814 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 966 968 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 969 971 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 972 974 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1017 1018 1001 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 1147 1148 1131 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
In contrast to Bax [11,15,26], the distributions of Bax 30-192 or Bax 30-146 were largely unchanged by Bcl-xL (Figure 6B-C). The TM1 domain/alpha5-alpha6 helices (amino acids 110-146) in Bax bring about membrane insertion and cytochrome c release from mitochondria in cell-free assays [29,33]. The substitution of charged residues in the alpha5-alpha6 helices of Bax resulted in its constitutive localization to mitochondria, akin to gain-of-function mutants and increased binding to Bcl-xL [47]. Despite consistent differences from Bax in regulation by Bcl-xL, the N-terminal deletion mutants immunoprecipitated ectopically expressed Bcl-xL (Figure 6D). This is not unexpected as the association of apoptotic with anti-apoptotic proteins does not culminate in the inhibition of pro-apoptotic activity [17,43-45,48]. Further, Bax 30-192 triggered caspase-9 dependent apoptosis and localized with Bid and Bim conventionally associated with regulated activity of Bax [15,48,49] a distribution largely unchanged by Bcl-xL. In our experiments the effect of the TM1 domain was mitigated by the inclusion of the N-terminal region i.e. Bax-1-146 (Figure 7).
###end p 52
###begin p 53
###xml 43 45 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 897 899 897 899 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1158 1160 1158 1160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1248 1252 1248 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C&#8211;D</xref>
###xml 1254 1258 1254 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E&#8211;F</xref>
###xml 1263 1265 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8F</xref>
###xml 568 572 <span type="species:ncbi:9696">Puma</span>
The anti-apoptotic proteins Bcl-2 and Bcl-xL are not functionally equivalent and the differences in the regulation of Bax 30-105 (Figure 3C) likely reflect differences in affinities of the mutant for the anti-apoptotic proteins. Such differences in functional interactions between pro-survival members and the pro-apoptotic or BH3 only proteins (BOPs) have been previously reported [17,50]. The BOPs are thought to be critical mediators of the activation of Bax/Bak although the mechanism underlying this activation is unresolved. Thus, 'activator" BOPs (Bid, Bim and Puma) have been reported to directly bind Bax and Bak triggering activation of the latter and are assisted in this function by "derepressor" BOP (Noxa, Bad etc.) which bind anti-apoptotic proteins [17]. On the other hand there is compelling evidence that BOP trigger the activation of Bax principally by binding Bcl-2/Mcl-1/Bcl-xL [48] obviating a requirement for direct interactions with Bax/Bak except in some conditions [51]. Bax 30-105 fulfills several criteria associated with BH3 domain only proteins triggering activation of endogenous Bax (which colocalized with Bid and Bim); Bcl-xL dependence and in the requirement for endogenous Bax-Bak for apoptotic function (Figure 3C-D, 4E-F and 8F).
###end p 53
###begin p 54
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 167 169 167 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 379 380 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 458 460 458 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 669 671 669 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
We do not know the mechanism underlying the lack of regulation of Bax 30-192 and Bax 30-146 by Bcl-xL. The constitutive association of Bax 30-192 and 30-146 with Bcl-xL may arise from structural changes in the deletion mutants culminating in a greater affinity (compared to Bax) for the anti-apoptotic protein. This may permit the mutants to sequester ectopically expressed Bcl-xL. On the other hand the association may impose conformational changes on Bcl-xL such that the latter is rendered functionally inactive and thereby unable to regulate apoptotic damage. That the pattern of Bid distribution in cells expressing Bax or Bax 30-105 changes on co-expressing Bcl-xL but not in cells that express Bax 30-192 provides some support for this possibility.
###end p 54
###begin p 55
###xml 116 118 116 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 215 217 207 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 297 298 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 395 397 387 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 927 929 919 921 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1037 1039 1029 1031 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1129 1131 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 1287 1289 1279 1281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1507 1508 1499 1500 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Analysis of local sequence similarities indicate that sub-optimal alignments reside at the interacting site of Bcl-xL and Bax TM1 helices. Sub-optimal sequence alignment between TM1 of Bax and alpha5-alpha6 of Bcl-xL suggests that the TM1 might block a productive functional interaction with Bcl-xL. The absence of N-terminal residues in Bax leads to a dramatic effect in its regulation by Bcl-xL in apoptotic function. The deletion analysis of Bax suggests that the N-terminal residues that are spatially interacting with the BH2 helix are absolutely required for (and may drive) the normal and necessary structural alterations in TM1 helices such that the anti-apoptotic elements can regulate its function. These are currently being investigated by detailed molecular dynamics simulations as well as studying the effect of additional mutations in Bax. The TM2 region in Bax may not be a crucial structural antagonist to Bcl-xL since the removal of TM2 results in a mutant (Bax 30-171) whose apoptotic activity is not regulated by Bcl-xL in the Jurkat and the HEK cell lines. Thus we propose (as depicted in the model in Figure 10) that the N-terminal "switch" of 29 residues is necessary to produce the required structural alterations in Bax such that TM1.1 is displaced from the Bcl-xL interacting site. In the absence of the N-terminal switch, this natural "trigger" mechanism is abolished and the TM helices continue to act as 'structural valves' where the protein remains closed to inhibition by Bcl-xL-like proteins.
###end p 55
###begin p 56
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A model summarizing the behavior of deletion mutants of Bax</bold>
###xml 421 423 421 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 503 504 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
A model summarizing the behavior of deletion mutants of Bax. The deletion constructs are named according to the beginning and end residue numbers. Different regions of Bax: N-terminal 29 residues, BH3 helix, the first and second helices of TM1 region (TM1.1 and TM1.2), BH2 helix and TM2 region, are color-coded as cyan, red, green, blue and purple, respectively. Constructs whose apoptotic activity is regulated by Bcl-xL are in shaded boxes. The open boxes show deletion mutants not regulated by Bcl-xL.
###end p 56
###begin title 57
Conclusion
###end title 57
###begin p 58
###xml 169 170 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Our experiments extend previous observations that the Bax N-terminus is an essential component in the regulation of Bax function by anti-apoptotic proteins such as Bcl-xL. Furthermore we propose that an intramolecular interaction between the N-terminus and the TM1 may be the mechanism underlying this regulation.
###end p 58
###begin title 59
Methods
###end title 59
###begin title 60
Cells and reagents
###end title 60
###begin p 61
###xml 537 539 537 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 193 197 <span type="species:ncbi:9913">calf</span>
###xml 701 706 <span type="species:ncbi:10090">Mouse</span>
###xml 710 716 <span type="species:ncbi:9986">Rabbit</span>
Jurkat, HEK and COS-7 cell lines and the Bax-Bak deficient MEF were maintained in culture in medium supplemented with antibiotics, glutamine (Invitrogen-Gibco, Carlsbad, CA) and 5 or 10% fetal calf serum (Hyclone, Logan, UT). Antibodies were procured from the following sources: to GFP and Bim from BD Biosciences (Franklin Lakes, NJ); to Bax and Bcl-2 from Santa Cruz (Santa Cruz, CA); to Cox-4 and and Alexa Fluor 555/Cy5 conjugated secondary antibodies from Invitrogen-Molecular Probes; to Bid from Cell Signaling Technology; to Bcl-xL from Abcam (Cambridge, UK); actin and clone 6A7 from Neomarker (Fremont, CA) respectively. Protein G agarose beads were from Pierce Biotechnology (Rockford, IL). Mouse or Rabbit True-Blot HRP (Ebiosciences, San Diego, CA) was used in the western blot analysis of immunoprecipitated proteins. All other chemicals were obtained from Calbiochem (San Diego, CA) or Invitrogen.
###end p 61
###begin title 62
Plasmids
###end title 62
###begin p 63
###xml 1004 1006 1004 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 1342 1344 1342 1344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 39 45 <span type="species:ncbi:10090">murine</span>
###xml 786 792 <span type="species:ncbi:10090">murine</span>
###xml 993 998 <span type="species:ncbi:9606">human</span>
###xml 1458 1461 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1472 1476 <span type="species:ncbi:262676">Mito</span>
A mammalian expression vector encoding murine full-length Bax was the kind gift of Peter Vandenabeele (University of Gent, Belgium). Bax-GFP and the deletion mutants were generated by PCR amplification and subcloning into the pEGFP-N1 vector (BD Clontech, Mountain View, CA) with GFP in-frame at the C- terminus. The following primers were used to generate the Bax and Bax mutants: Bax/Bax 1-171/Bax 1-146 forward 5' CCG CTC GAG ATG GAC GGG TCC GGG 3' Bax 30-192/Bax 30-171/Bax 30-146/Bax 30-105 forward 5' CCG CTC GAG ATG TTC ATC CAG GAT 3' Bax/Bax 30-192 reverse 5' CCC AAG CTT GCC CAT CTT CTT CCA 3' Bax 30-171/Bax 1-171 reverse 5' CCC AAG CTT CTG CCA TGT GGG 3' Bax 30-146/Bax 1-146 reverse 5'CCC AAG CTT CTC ACG GAG GAA 3' Bax 30-105 reverse 5' CCC AAG CTT GAA GTT GCC ATC 3'. The murine Bcl-2 plasmid was obtained from Upstate (Charlottesville, VA). The dominant negative caspase 9 construct was the kind gift of C. Vincenz (University of Michigan Medical School, Ann Arbor, MI) and the human Bcl-xL plasmid was from Richard J. Youle (National Institutes of Health, Bethesda, MD). CA-Akt was from Upstate (Charlottesville, VA). Monomeric RFP (mRFP) plasmid was originally from Roger Y. Tsien (University of California, San Diego, CA) and obtained through Satyajit Mayor (National Centre for Biological Sciences, Bangalore, India). Bcl-xL was subcloned into the pUSEAmp mammalian expression vector and was also subcloned at the 3' end of mRFP under the CMV promoter. Mito-DsRed was obtained from V. Sriram (National Centre for Biological Sciences, Bangalore, India). The sequence of all constructs was verified by automated sequencing (Microsynth, Balgach, Switzerland). The alanine substitution mutant Bax-Ala3 (substituted on T14, S15 and S16) was generated at Everogen (Moscow, Russia).
###end p 63
###begin title 64
Transient transfections and assay for nuclear damage
###end title 64
###begin p 65
###xml 486 487 483 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Jurkat and 2B4 cells were transfected by electroporation. Briefly 3-5 million cells were electroporated at 250 V and 960 muF and cultured for 12 hours prior to analysis. HEK and COS-7 cells were plated at 0.4-0.5 million cells/ml and MEF at 0.3 million/ml 12-15 hours prior to transfection. Cells were transfected using lipofectaime 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Cos-7 cells were transfected with 0.2 mug of Bax constructs and 2 mug Bcl-xL. 12-15 hours later staurosporine was added at a final concentration of 1 muM and the cultures continued for an additional 3-4 hours before analysis.
###end p 65
###begin p 66
Transfected cells were harvested and stained for 3 minutes at ambient temperatures in the dark using the Hoechst 33342 (1 mug/ml) and assessed for apoptotic nuclear damage. GFP positive cells were viewed under the UV filter of the fluorescence microscope and nuclear morphology scored for a minimum of 200 cells in each experimental condition. In a minimum of two experiments in each set of data samples were scored double-blind. Statistical significance of the differences between groups was assessed by the Student's t-test and is indicated by an * in the figures.
###end p 66
###begin title 67
Sub-cellular fractionation
###end title 67
###begin p 68
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
The protocol followed has been previously described [52]. Briefly, 1 million cells were incubated in 100 mul homogenization buffer (250 mM sucrose, 20 mM Hepes, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, pH 7.2 supplemented with 2 mug/ml aprotinin, leupeptin and pepstatin) for 15 min on ice. Cells were mechanically disrupted by passing through a 26-gauge needle 15 times followed by a 30-gauge needle 15 times. Cell lysates were centrifuged at 750 g for 10 min at 4degreesC to remove unlysed cells and nuclei. The supernatant was centrifuged at 12,000 g for 20 min at 4degreesC to obtain the pellet enriched in mitochondria and the supernatant enriched for cytosolic proteins. Equivalent volumes of cytosolic and mitochondrial fractions were used for western blot analysis to assess the relative distribution of Bax and the mutants. The densitometry analysis of western blots was performed using Image Gauge software Version-3 (Fujifilm Science, Japan)
###end p 68
###begin title 69
Immunoprecipitation
###end title 69
###begin p 70
###xml 239 240 237 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 242 243 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 511 512 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
In each group two million cells were harvested and lysed in 500 mul of CHAPS lysis buffer (1% CHAPS in 50 mM Tris-Cl, 150 mM NaCl, 1 mM EDTA, pH7.4 supplemented with 2 mug/ml aprotinin, leupeptin, pepstatin, 1 mM PMSF, 1 mM NaF and 1 mM Na3OV4) by 3 freeze thaw cycles in liquid nitrogen and 37degreesC followed by an incubation (30 minutes) at 4degreesC on a cell rotator. The lysate was centrifuged at 3000 rpm to remove debris and unlysed cells. The supernatant was incubated with 10 mug of antibody to Bcl-xLat 4degreesC for 1 hour on a cell mixer. 80 mul of washed Protein-G agarose beads were then added to the sample and mixed by gentle rotation for another 2 hours at 4degreesC. Beads were pelleted by centrifugation at 1700 rpm and subsequently washed 4 times with chilled PBS. After the final wash the beads-complex was pelleted by centrifugation at 2500 rpm and boiled in SDS lysis buffer for 10 minutes before western blot analysis.
###end p 70
###begin title 71
Immunochemistry and confocal imaging
###end title 71
###begin p 72
Cells washed with PBS and fixed in 4% paraformaldehyde for 15 minutes at ambient temperature were permeabilized with 0.2% CHAPS in PBS (permeabilization buffer) for 30 minutes on ice and blocked for 1 hour on ice with 5% BSA diluted in permeabilization buffer. Cells were incubated with primary antibodies diluted in blocking buffer for 1-2 hours on ice followed by a wash with permeabilization buffer. The cells were finally incubated with Alexa Fluor 555 and/or Cy5 conjugated secondary antibodies diluted in blocking buffer for 1 hour on ice. Cells were also counterstained with Hoechst 33342 before the final wash and imaged.
###end p 72
###begin p 73
Cells were imaged using a Bio-Rad MRC 1024 laser scanning confocal microscope equipped with Argon-Krypton laser and 60X, NA 1.4 objective lens. Fluorescence images of cells were recorded with sequential excitation and emission conditions using appropriate optics. The acquired images were processed for co-localization analysis using Image J1.34s software. For the analysis of endogenous Bid, Bim or Bax, samples were imaged using a LSM 510 Meta laser scanning confocal microscope (Carl Zeiss, Jena, Germany) equipped with Argon, Helium-Neon lasers and 63X, NA 1.4 objective. The fluorescence images for GFP tagged, Alexa Fluor 555 and Cy5 labeled proteins were acquired with sequential excitation (488 nm, 543 nm and 633 nm respectively) and emission conditions using appropriate optics. The nuclear morphology images were acquired using two photon excitation of single plane with 750 nm pulsed laser (Spectra-Physics, CA). Images were processed for co-localization analysis using Image J1.34s and LSM Meta (Carl Zeiss, Jena, Germany) software.
###end p 73
###begin title 74
Transgenic flies and genetic interaction studies
###end title 74
###begin p 75
###xml 113 138 113 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yw; +; Ki P(&#916;2-3ry+) </italic>
###xml 745 764 741 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vestigial (vg)-GAL4</italic>
###xml 766 776 762 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist-GAL4</italic>
###xml 778 790 774 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eyeless-GAL4</italic>
###xml 792 807 788 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scalloped-GAL4 </italic>
###xml 810 823 806 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">collagen-GAL4</italic>
###xml 855 866 851 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Bax-GFP, Bax 30-192-GFP and Bcl-2 were cloned in the UAS vector pUAST. The resulting plasmids were injected into yw; +; Ki P(Delta2-3ry+) embryos using standard procedures. Several independent transformant lines were obtained by P-element transformation for each transgene. A minimum of two lines in each case were characterized for further analysis. Bax-GFP insertion was mapped to chromosomes III and I for BA64III and BA13I transgenic lines respectively. Bax 30-192-GFP insertion was mapped to chromosome II and I for DBA8II and DBA8IA fly lines respectively. Bcl-2 insertion was mapped to chromosome I and III for BC57I and BC24III fly lines respectively. A single copy transformant fly line for each transgene was crossed to flies carrying vestigial (vg)-GAL4, twist-GAL4, eyeless-GAL4, scalloped-GAL4 or collagen-GAL4. Flies were raised on standard Drosophila medium at 25degreesC.
###end p 75
###begin title 76
Authors' contributions
###end title 76
###begin p 77
NP contributed to the design and performance of experiments and the genetic analysis. CK contributed to the sequence analysis. VD carried out the immunoprecipitation analysis. LP performed functional assays with the site-directed mutant. RS coordinated and performed the sequence alignment and analysis, contributed to the design of experiments and the writing of the paper. AS contributed to the design and conducted experiments and the writing of the paper. All authors have read and approved the final manuscript.
###end p 77
###begin title 78
Acknowledgements
###end title 78
###begin p 79
We acknowledge M.K. Mathew (NCBS) for comments and discussion. The Bax-Bak double knock out MEF were generously gifted by Dr. Anthony G. Letai, Dana Farber Cancer Institute, MA, USA and were obtained from Dr. TR Santhosh Kumar, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India. We are grateful to several laboratories and colleagues for the generous gifts of reagents used in this study. We acknowledge H. Krishnamurthy and the Imaging and Flowcytometry Facility at NCBS.
###end p 79
###begin p 80
NP and VD are funded by fellowships from the Council of Scientific and Industrial Research, India and the Indian Council of Medical Research, India respectively. The study was funded by a Senior Research Fellowship in Biomedical Sciences from the Wellcome Trust, UK to RS and AS.
###end p 80
###begin article-title 81
Breaking the mitochondrial barrier
###end article-title 81
###begin article-title 82
The pathophysiology of mitochondrial cell death
###end article-title 82
###begin article-title 83
The Bcl-2 protein family: arbiters of cell survival
###end article-title 83
###begin article-title 84
Bcl-2-family proteins: the role of the BH3 domain in apoptosis
###end article-title 84
###begin article-title 85
The BH3 domain of Bax is sufficient for interaction of Bax with itself and with other family members and it is required for induction of apoptosis
###end article-title 85
###begin article-title 86
Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death
###end article-title 86
###begin article-title 87
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis
###end article-title 87
###begin article-title 88
###xml 19 20 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies
###end article-title 88
###begin article-title 89
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
The structure of a Bcl-XL/Bim fragment complex: Implications for Bim Function
###end article-title 89
###begin article-title 90
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
###end article-title 90
###begin article-title 91
Movement of Bax from the cytosol to mitochondria during apoptosis
###end article-title 91
###begin article-title 92
Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH
###end article-title 92
###begin article-title 93
Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis
###end article-title 93
###begin article-title 94
Bcl-2-family proteins and the role of mitochondria in apoptosis
###end article-title 94
###begin article-title 95
The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA
###end article-title 95
###begin article-title 96
BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly
###end article-title 96
###begin article-title 97
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
###end article-title 97
###begin article-title 98
A membrane-targeted BID BCL-2 homology 3 peptide is sufficient for high potency activation of BAX in vitro
###end article-title 98
###begin article-title 99
Bax cleavage is mediated by calpain during drug-induced apoptosis
###end article-title 99
###begin article-title 100
Participation of Bax-alpha in IFN-alpha-mediated apoptosis in Daudi B lymphoma cells
###end article-title 100
###begin article-title 101
Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax
###end article-title 101
###begin article-title 102
Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax
###end article-title 102
###begin article-title 103
N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C c release and apoptotic cell death
###end article-title 103
###begin article-title 104
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Bax kappa, a novel Bax splice variant from ischemic rat brain lacking an ART domain, promotes neuronal cell death
###end article-title 104
###begin article-title 105
###xml 143 151 <span type="species:ncbi:9606">patients</span>
The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients
###end article-title 105
###begin article-title 106
Conformation of the Bax C-terminus regulates subcellular location and cell death
###end article-title 106
###begin article-title 107
Regulated targeting of BAX to mitochondria
###end article-title 107
###begin article-title 108
The N-terminal end of Bax contains a mitochondrial-targeting signal
###end article-title 108
###begin article-title 109
Distinct domains control the addressing and the insertion of Bax into mitochondria
###end article-title 109
###begin article-title 110
The Bax N terminus is required for negative regulation by the mitogen-activated protein kinase kinase and Akt signaling pathways in T-cells
###end article-title 110
###begin article-title 111
The HMMTOP transmembrane topology prediction server
###end article-title 111
###begin article-title 112
Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis
###end article-title 112
###begin article-title 113
Bax-induced cytochrome c release from mitochondria depends on alpha-helices-5 and -6
###end article-title 113
###begin article-title 114
###xml 52 55 <span type="species:ncbi:9606">man</span>
Apoptosis in Drosophila: neither fish nor fowl (nor man, nor worm)
###end article-title 114
###begin article-title 115
###xml 7 13 <span type="species:ncbi:10090">murine</span>
Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations
###end article-title 115
###begin article-title 116
Apoptosomes: engines for caspase activation
###end article-title 116
###begin article-title 117
Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
###end article-title 117
###begin article-title 118
Boo, a novel negative regulator of cell death interacts with Apaf-1
###end article-title 118
###begin article-title 119
Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis
###end article-title 119
###begin article-title 120
DDBASE2.0: updated domain database with improved identification of structural domains
###end article-title 120
###begin article-title 121
Alignment and searching for common protein folds using a data bank of structural templates
###end article-title 121
###begin article-title 122
Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2
###end article-title 122
###begin article-title 123
###xml 92 97 <span type="species:ncbi:4932">yeast</span>
Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells
###end article-title 123
###begin article-title 124
Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL
###end article-title 124
###begin article-title 125
Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing
###end article-title 125
###begin article-title 126
The p18 truncated form of Bax behaves like a Bcl-2 homology domain 3-only protein
###end article-title 126
###begin article-title 127
The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-X(L)
###end article-title 127
###begin article-title 128
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
###end article-title 128
###begin article-title 129
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
###end article-title 129
###begin article-title 130
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
###end article-title 130
###begin article-title 131
A stapled BID BH3 helix directly binds and activates BAX
###end article-title 131
###begin article-title 132
Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis
###end article-title 132

